Salut Loic

Cela fait plaisir d'avoir de tes nouvelles, alors que je projetais de te 
contacter aujourd'hui (véridique!)"

Comment cela va t'il a Quimper? Ne serais tu pas intéressé pas un poste de 
titulaire plein temps plus proche de ton domicile?

Je reviens prochainement

Erwan


Dr Erwan L'Her, MD, PhD
Intensiviste et Urgentologue
Professeur au Dép. Médecine Familiale et Médecine d'Urgence
et titulaire de la Chaire de recherche en médecine d'urgence
Université Laval/CHAU Hôtel-Dieu de Lévis





LoÏc PICAULT <[email protected]> 
2009-03-26 06:20
Veuillez répondre à
[email protected]


A
[email protected]
cc

Objet
URG-L: RE URG-L: RE URG-L: FW: InfoPOEM: Intensive glucosecontrol 
ineffectiveinICUpatients








bonjour,

j'espère que tu vas bien et que ton séjour au canada est conforme à tes 
attentes....

amitiés
 
loic picault




> Message du 25/03/09 21:16
> De : [email protected]
> A : [email protected]
> Copie à : 
> Objet : URG-L: RE URG-L: RE URG-L: FW: InfoPOEM: Intensive glucose 
control ineffectiveinICUpatients
> 
> 
> Effectivement, ne revenons pas complètement en arrière! 
> Le maintien de glycémie "raisonnable" est sans doute souhaitable. 
> 
> Pour mémoire, dans le dernier numéro de Lancet: 
> 
> Intensive insulin therapy for patients in paediatric intensive care: a 
prospective, randomised controlled study. 
> Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den 
Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van 
Cromphaut S, Schetz M, Van den Berghe G. 
> Department of Intensive Care Medicine (Paediatric Intensive Care Unit), 
Catholic University Leuven, Leuven, Belgium. 
> BACKGROUND: Critically ill infants and children often develop 
hyperglycaemia, which is associated with adverse outcome; however, whether 
lowering blood glucose concentrations to age-adjusted normal fasting 
values improves outcome is unknown. We investigated the effect of 
targeting age-adjusted normoglycaemia with insulin infusion in critically 
ill infants and children on outcome. METHODS: In a prospective, randomised 
controlled study, we enrolled 700 critically ill patients, 317 infants 
(aged <1 year) and 383 children (aged >or=1 year), who were admitted to 
the paediatric intensive care unit (PICU) of the University Hospital of 
Leuven, Belgium. Patients were randomly assigned by blinded envelopes to 
target blood glucose concentrations of 2.8-4.4 mmol/L in infants and 
3.9-5.6 mmol/L in children with insulin infusion throughout PICU stay 
(intensive group [n=349]), or to insulin infusion only to prevent blood 
glucose from exceeding 11.9 mmol/L (conventional group [n=351]). Patients 
and laboratory staff were blinded to treatment allocation. Primary 
endpoints were duration of PICU stay and inflammation. Analysis was by 
intention to treat. This study is registered with ClinicalTrials.gov, 
number NCT00214916. FINDINGS: Mean blood glucose concentrations were lower 
in the intensive group than in the conventional group (infants: 4.8 [SD 
1.2] mmol/L vs 6.4 [1.2] mmol/L, p<0.0001; children: 5.3 [1.1] mmol/L vs 
8.2 [3.3] mmol/L, p<0.0001). Hypoglycaemia (defined as blood glucose 
median) stay in PICU was 132 (38%) in the intensive group versus 165 (47%) 
in the conventional group (p=0.013). Nine (3%) patients died in the 
intensively treated group versus 20 (6%) in the conventional group 
(p=0.038). INTERPRETATION: Targeting of blood glucose concentrations to 
age-adjusted normal fasting concentrations improved short-term outcome of 
patients in PICU. The effect on long-term survival, morbidity, and 
neurocognitive development needs to be investigated. FUNDING: Research 
Foundation (Belgium); Research Fund of the University of Leuven (Belgium) 
and the EU Information Society Technologies Integrated project "CLINICIP"; 
and Institute for Science and Technology (Belgium). 
> 
> 
>  Dr Erwan L'Her, MD, PhD
> Intensiviste et Urgentologue
> Professeur au Dép. Médecine Familiale et Médecine d'Urgence
> et titulaire de la Chaire de recherche en médecine d'urgence
> Université Laval/CHAU Hôtel-Dieu de Lévis
> 
> 
> 
> 
> 
patrick archambault 
> 2009-03-25 15:24 

Veuillez répondre à
> [email protected]

> 


A
[email protected] 
cc
 
Objet
URG-L: RE URG-L: FW: InfoPOEM: Intensive glucose control ineffective 
inICUpatients

> 

 
 

> 

> 
> 
> 
> 
> Merci Erwan! 
> 
> La fin de Van den Berghe?!? 
> 
> Il faudra lire l'article avec attention, mais il semble qu'il faudra en 
effet maintenant viser (comme avant l'étude de Van den Berghe) < 10 comme 
contrôle glycémique aux soins intensifs! 
> 
> Mais j,aime bien le commentaire de l'éditorial: "Notwithstanding, it 
would be a disservice to our critically ill patients to infer from the 
NICE-SUGAR data that neglectful glycemic control involving haphazard 
therapeutic approaches (e.g., use of insulin "sliding scales") — all too 
common a decade ago — is again acceptable practice in our ICUs." 
> 
> Patrick
> 
> 2009/3/25 <[email protected]> 
> 
> Publié hier !!! 
> 
> Intensive versus Conventional Glucose Control in Critically Ill Patients 

> The NICE-SUGAR Study Investigators 
 
> ABSTRACT 
> Background The optimal target range for blood glucose in critically ill 
patients remains unclear. 
> Methods Within 24 hours after admission to an intensive care unit (ICU), 
adults who were expected to require treatment in the ICU on 3 or more 
consecutive days were randomly assigned to undergo either intensive 
glucose control, with a target blood glucose range of 81 to 108 mg per 
deciliter (4.5 to 6.0 mmol per liter), or conventional glucose control, 
with a target of 180 mg or less per deciliter (10.0 mmol or less per 
liter). We defined the primary end point as death from any cause within 90 
days after randomization. 
> Results Of the 6104 patients who underwent randomization, 3054 were 
assigned to undergo intensive control and 3050 to undergo conventional 
control; data with regard to the primary outcome at day 90 were available 
for 3010 and 3012 patients, respectively. The two groups had similar 
characteristics at baseline. A total of 829 patients (27.5%) in the 
intensive-control group and 751 (24.9%) in the conventional-control group 
died (odds ratio for intensive control, 1.14; 95% confidence interval, 
1.02 to 1.28; P=0.02). The treatment effect did not differ significantly 
between operative (surgical) patients and nonoperative (medical) patients 
(odds ratio for death in the intensive-control group, 1.31 and 1.07, 
respectively; P=0.10). Severe hypoglycemia (blood glucose level, 40 mg per 
deciliter [2.2 mmol per liter]) was reported in 206 of 3016 patients 
(6.8%) in the intensive-control group and 15 of 3014 (0.5%) in the 
conventional-control group (P<0.001). There was no significant difference 
between the two treatment groups in the median number of days in the ICU 
(P=0.84) or hospital (P=0.86) or the median number of days of mechanical 
ventilation (P=0.56) or renal-replacement therapy (P=0.39). 
> Conclusions In this large, international, randomized trial, we found 
that intensive glucose control increased mortality among adults in the 
ICU: a blood glucose target of 180 mg or less per deciliter resulted in 
lower mortality than did a target of 81 to 108 mg per deciliter. 
(ClinicalTrials.gov number, NCT00220987 [ClinicalTrials.gov] .) 
> Dr Erwan L'Her, MD, PhD
> Intensiviste et Urgentologue
> Professeur au Dép. Médecine Familiale et Médecine d'Urgence
> et titulaire de la Chaire de recherche en médecine d'urgence
> Université Laval/CHAU Hôtel-Dieu de Lévis
> 
> 
> 
patrick archambault <[email protected]> 
> 2009-03-25 13:15 
> 

Veuillez répondre à
> [email protected]
> 

> 

A
[email protected] 
cc
 
Objet
URG-L: FW: InfoPOEM: Intensive glucose control ineffective inICU patients

> 
> 

 
 

> 
 
> 
> 
> 
> 
> 
> Les résultats de l'étude NICE-Sugar seront très intéressants à avoir 
lorsque publiés: 
http://www.ncbi.nlm.nih.gov/pubmed/19281445?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
 

> 
> Patrick Archambault
> 
> 2009/3/25 M. Chenier <[email protected]> 
> C'est pas la seule dans le domaine du contrôle intensif de la glycémie:
> 
> http://www.ncbi.nlm.nih.gov/pubmed/18539917?dopt=Abstract
> http://www.ncbi.nlm.nih.gov/pubmed/18728267?dopt=Abstract 
> M. Chénier 
> [email protected] 
> 
> 
> Alain Vadeboncoeur wrote: 
> Fascinant quand même de nombre d'études qui se publient sur L'ABSENCE de 
gains dans divers contextes d'un contrôle serré de la glycémie! 
>   
> Alain 
> 
> 
From: [email protected] [mailto:[email protected]] On Behalf Of Équipe 
éditoriale de amc.ca
> Sent: 25 mars 2009 04:00
> To: [email protected]
> Subject: InfoPOEM: Intensive glucose control ineffective in ICU patients 

Pour assurer la livraison de ce courriel dans votre boîte de réception, 
veuillez ajouter [email protected] à votre carnet de contacts. 
 

> 

 
Intensive glucose control ineffective in ICU patients 
> Clinical question 
> Does tight control of blood glucose improve survival of patients in a 
medical surgical intensive care unit? 
> Bottom line 
> Tight control of blood glucose levels -- 80 mg/dL to 110 mg/dL (4.4-6.1 
mmol/L) -- did not decrease mortality or other measured outcomes in 
patients admitted to an intensive care unit (ICU) with hyperglycemia. 
Hypoglycemia was much more common and was associated with an increased 
mortality. A meta-analysis has found similar results. (LOE = 1b) 
> Reference 
> Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional 
insulin therapy: A randomized controlled trial in medical and surgical 
critically ill patients. Crit Care Med 2008;36(12):3190-3197. 
> Study design 
> Randomized controlled trial (nonblinded) 
> Funding
> Foundation 
> Allocation
> Concealed 
> Setting
> Inpatient (ICU only) 

> 



 
 Obtenez des crédits 
>  Mainpro 
 
 Discutez de cet
>  InfoPOEM 
 
 Archives 
 
 Bilan des crédits 
 
 Plus de FMC / DPC

> 

> 
> 




> Publicité 

> 
> 
> 



 
 Bibliothécaire de l'AMC

> 

> 
> 



 
 Envoyez-nous vos commentaires

> 

> 
Synopsis 
> The Saudi Arabian investigators conducting this study enrolled 523 
adults in a medical surgical ICU. The unit was closed and covered at all 
times by an intensivist. The patients (75% men) did not have type 1 
diabetes, though 40% had a history of type 2 diabetes. The average blood 
glucose level was 194 mg/dL (10.8 mmol/L) in the intensive insulin group 
and 210 mg/dL (11.7 mmol/L) in the conventional insulin group. Most of the 
patients were nonoperative and were critically ill; 85% were mechanically 
ventilated and 65% were receiving vasopressors, with a mortality rate was 
approximately 15%. All patients received an infusion of regular insulin 
and were randomly assigned, using concealed allocation, to have their 
blood glucose maintained at 80 mg/dL to 110 mg/dL (4.4 - 6.1 mmol/L) in 
the intensive insulin group and 180 mg/dL to 200 mg/dL (10.0-11.1 mmol/L) 
in the conventional treatment group. Analysis was by intention to treat. 
The main outcome, in-ICU mortality, was not different between the 2 
groups. At least one episode of hypoglycemia occurred in 28.6% of patients 
in the tight control group and 3.1% of patients in the conventional 
treatment group. In-ICU mortality was higher among those who had 
hypoglycemia (23.8% vs 13.7%; P = .02). There was no difference in 
in-hospital mortality, ICU or hospital length of stay, ventilation 
duration, infections, or the need for transfusion. These results are 
similar to those found in a previous meta-analysis (JAMA 
2008;300(8):933-944). 
> Discutez de cet InfoPOEM 

> 

Archives 
> InfoPOEMs (contenu anglais) | CLIPs (contenu anglais) | Critique et 
pratique 
> Ressources cliniques 
> Accueil | Manuels * | Revues * | Information médicaments * | Tests de 
laboratoire * | InfoPOEMs | Guide de pratique clinique | 
> 
> Documents d'information pour les patients * | Bibliothécaire de l'AMC * 
> Raccourcis 
> MD Consult * | STAT!Ref * | [email protected] * | OVID Medline * | Revues EBSCO 
* | JAMC | Essential Evidence Plus | MedCalc 3000 * 
> FMC / DPC 
> Voir les cours en ligne | Bilan des crédits 
> Gestion de la pratique 
> Accueil | Créez un site Web de pratique | Clinique informatisée | Bureau 
| Dotation en personnel | Finances | Juridique et vie privée 
> * Service aux membres AMC
> 
 
 
> 
 
POEMs veut dire "Patient-Oriented Evidence that Matters". 
> Désirez-vous changer le format de vos courriels d'InfoPOEMs quotidiens 
ou votre adresse courriel de la liste d'InfoPOEMs quotidiens? 
> Gérez vos options d'InfoPOEMs quotidiens à partir du site Web amc.ca. 
> Cliquez ici pour vous désabonner. 
> Copyright © 1995-2009 InfoPOEM, Inc. www.infopoems.com. Tous droits 
réservés. 
> Copyright © 2009 Association Médicale Canadienne, Tous droits réservés. 
> 
> 
> 
> 
> 
> 
> 
> 




Répondre à